v3.19.2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Sales $ 3,246,038 $ 987,431
Cost of Sales 1,630,166 402,665
Gross Margin 1,615,872 584,766
Operating expenses    
Sales and marketing 2,339,359 1,989,837
Research and development 3,174,892 2,825,200
General and administrative 3,893,393 3,585,484
Share-based compensation expense (Notes 11) 1,347,399 1,540,580
Amortization (Note 4) 278,997 323,905
Depreciation (Note 7) 69,212 89,026
Total operating expenses 11,103,252 10,354,032
Other (income) expenses    
Accretion expense (Note 8) 3,266,918 1,937,308
Share premium 0 1,249,994
Fair Value Adjustment (Note 8) (337,923) 0
Gain/Loss on mark to market re-evaluation (Note 10(c)) (2,048,697) 376,674
Other expense 262,596 1,297,205
Other income (73,166) (107,656)
Foreign exchange (507) 102,999
Total other expenses 1,069,221 4,856,524
Net loss and comprehensive loss for the period $ (10,556,601) $ (14,625,790)
Loss per share - basic and diluted $ (4.47) $ (21.73)
Weighted average number of shares outstanding – basic and diluted 2,363,107 673,203

Source